Dividends Calendar Earnings Calendar
CRVS

CRVS | Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Burlingame, California, United States

Trade prices

  • Volume: 225M
  • Market Cap: 205.32M
  • Prev closed:
  • Open: 7
  • High: 8.11
  • Low: 6.81
  • 52 week low: 1.86
  • 52 week high: 9.54
  • Dividends:No Dividends

Next ER: November 4, 2021 



Top Stories (CRVS)

    Company Profile

    Corvus Pharmaceuticals is an immunology focused biopharmaceutical company developing drugs and antibodies that target the most critical cellular elements of the immune system

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 4, 2021
    August 5, 2021- / -0.33- / -
    May 6, 2021- / -0.315- / -
    March 25, 20210.92 / -0.3225- / -
    October 29, 2020-0.33 / -0.24- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Oct 1, 2021 4.810 4.990
    5.390
    4.810
    7.55M -0.62%
    Sep 30, 2021 4.840 6.020
    6.250
    4.800
    10.97M -23.42%
    Sep 29, 2021 6.320 6.750
    7.110
    6.120
    3.49M -8.27%
    Sep 28, 2021 6.890 7.560
    7.730
    6.540
    4.02M -10.17%
    Sep 27, 2021 7.670 7.000
    8.110
    6.810
    13.20M 12.79%
    Sep 24, 2021 6.800 6.920
    7.360
    6.650
    4.02M -3.27%
    Sep 23, 2021 7.030 7.210
    7.420
    6.540
    6.05M -6.14%
    Sep 22, 2021 7.490 8.400
    8.890
    7.040
    29.24M -12.19%
    Sep 21, 2021 8.530 5.530
    9.540
    5.320
    84.27M 38.25%
    Sep 20, 2021 6.170 4.960
    6.900
    4.780
    73.73M 15.98%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:52

    News

    News for (CRVS)

    This company doesn't provide a dividend.


    Talk about Corvus Pharmaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 4, 2021 (Same day)

    amzn gm baba twtr ea atvi shop syna sq fb gpro nok 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 67
    HOLD 33
    SELL 0

    Their Official Profiles 

    LinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis